Skip to main content

Table 2 Cycle characteristics and hormone levels for the COVID-19 and the control groups during COS

From: Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation

Group

Control

(N = 21)

COVID-19

(N = 17)

P value

Protocol

  

0.064b

Antagonist

16

8

 

Long luteal

5

9

 

Total dosage of gonadotropin (IU)

2700.0 (2400 to 4350)

2825.0 (2375 to 3900)

0.705 c

Duration of COS (d)

10.5 (10 to 11)

11.5 (11 to 12)

0.075c

T1

   

P

2.12 (0.75 to 3.07)

2.08 (1.54 to 3.05)

0.758c

E2

671.14 (104.35 to 3672.88)

574.93 (344.17 to 1438.63)

0.988c

LH

4.20 ± 1.80

1.78 ± 1.86

0.000a

T2

   

P

2.52 ± 1.55

2.82 ± 1.43

0.523a

E2

4928.50 ± 3354.94

3567.29 ± 2299.30

0.173 a

LH

2.17 ± 1.74

1.91 ± 1.47

0.356a

T3

   

P

3.51 ± 2.34

3.91 ± 1.04

0.489a

E2

8992.32 ± 5869.93

10996.26 ± 5687.55

0.296a

LH

1.75 (1.04 to 2.24)

1.41 (0.84 to 2.64)

0.177c

  1. P, progestin; E2, estradiol; LH, luteinizing hormone. T1, the serum hormone levels on day 5; T2, the serum hormone levels on day 8; T3, the serum hormone levels on the trigger day. a independent sample t-tests; b chi-square test; c Mann-Whitney U tests